Cargando…
MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling
MicroRNAs (miRNAs) are thought to be involved in the development of cisplatin (DDP) resistance in gastric cancer (GC). Using RNA sequencing analysis (RNA-seq), we found that miR-95-3p is associated with DDP resistance in GC. We discovered that miR-95-3p is highly expressed in DDP-resistant GC tissue...
Autores principales: | Ni, Qingfeng, Zhang, Yan, Tao, Ran, Li, Xiaolong, Zhu, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034895/ https://www.ncbi.nlm.nih.gov/pubmed/33714198 http://dx.doi.org/10.18632/aging.202679 |
Ejemplares similares
-
Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors
por: Cha, Yoon Jin, et al.
Publicado: (2020) -
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
por: Hsieh, Yi-Hsien, et al.
Publicado: (2015) -
Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis
por: Guo, Qie, et al.
Publicado: (2019) -
Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity
por: Hu, S, et al.
Publicado: (2017) -
MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling
por: Cheng, Zhouyang, et al.
Publicado: (2021)